|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$11.39 |
$11.49 |
$10.83 |
$11.07 |
291.00K | 03/22/2024 |
$11.16 |
$11.47 |
$10.75 |
$10.80 |
175.20K | 03/25/2024 |
$10.75 |
$11.27 |
$10.75 |
$11.00 |
206.50K | 03/26/2024 |
$10.97 |
$11.15 |
$10.78 |
$10.89 |
123.00K | 03/27/2024 |
$11.04 |
$11.15 |
$10.98 |
$11.09 |
102.00K |
|
Fennec Pharmaceuticals is a biopharmaceutical company focused on its product candidate, PEDMARK® (sodium thiosulfate injection), which is used to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors. Co. has established Fennec HEARS, a single source program designed to connect PEDMARK® patients to both patient financial and product access support. The program provides assistance and resources, regardless of insurance type, that can address co-pays or lack of coverage when certain eligibility requirements are met. | |
|
Fennec Pharmaceuticals (FENC) has the following price history information. Looking back at FENC historical stock prices for the last five trading days, on March 21, 2024, FENC opened at $11.39, traded as high as $11.49 and as low as $10.83, and closed at $11.07. Trading volume was a total of 291.00K shares. On March 22, 2024, FENC opened at $11.16, traded as high as $11.47 and as low as $10.75, and closed at $10.80. Trading volume was a total of 175.20K shares. On March 25, 2024, FENC opened at $10.75, traded as high as $11.27 and as low as $10.75, and closed at $11.00. Trading volume was a total of 206.50K shares. On March 26, 2024, FENC opened at $10.97, traded as high as $11.15 and as low as $10.78, and closed at $10.89. Trading volume was a total of 123.00K shares. On March 27, 2024, FENC opened at $11.04, traded as high as $11.15 and as low as $10.98, and closed at $11.09. Trading volume was a total of 102.00K shares.
FENC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fennec Pharmaceuticals shares, starting with a $10,000 purchase of FENC, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/18/2017 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$11.37 |
|
End price/share: |
$11.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-2.46% |
|
Average Annual Total Return: |
-0.38% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,754.60 |
|
Years: |
6.53 |
|
|
|
Date |
Close |
03/21/2024 | $11.07 | 03/22/2024 | $10.80 | 03/25/2024 | $11.00 | 03/26/2024 | $10.89 | 03/27/2024 | $11.09 |
|
|